Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

Conclusion:
The available studies on spasticity treatment offer some insight to guide clinical practice but are of variable methodological quality. Large, well-designed trials are needed to confirm the effectiveness of antispasticity agents and to produce evidence-based treatment algorithms.

Source: Multiple Sclerosis - October 2, 2016 Category: Neurology Authors: Otero-Romero, S., Sastre-Garriga, J., Comi, G., Hartung, H.-P., Soelberg Sorensen, P., Thompson, A. J., Vermersch, P., Gold, R., Montalban, X. Tags: Review Source Type: research